Abstract:Background and purpose: Mutations in the PLA2G6 gene are causative of PLA2G6-associated neurodegeneration (PLAN), a spectrum of neurodegenerative conditions including infantile, childhood and adult onset forms. Methods: Seventeen North African patients with a clinical suspicion of infantile-onset PLAN underwent clinical, neurophysiological and neuroimaging examinations, and PLA2G6 sequencing. Haplotype analysis was performed to date the identified founder mutation. Results: All patients carried biallelic mutations in PLA2G6. Sixteen children had the commonest form of infantile-onset PLAN, with early onset of psychomotor regression, hypotonia, pyramidal and cerebellar signs, and abnormal ocular movements. The phenotype was highly homogeneous, with rapid development of severe spastic tetraparesis, cognitive impairment and optic atrophy. Neuroimaging showed cerebellar atrophy and claval hypertrophy to be the commonest and earliest signs, whilst cerebellar cortex hyperintensity and pallidal iron deposition were later findings. Motor or sensory-motor neuropathy and electroencephalogram fast rhythms were also frequent. Nine patients from six families shared the same founder mutation (p.V691del) which probably arose by the late seventeenth century. Only one patient fitted the diagnosis of the much rarer childhood-onset PLAN. Despite the early onset (18 months), clinical progression was slower, with behavioral disturbances and dystonia. Typical features of infantile-onset PLAN such as hypotonia, nystagmus/strabismus, optic atrophy, electroencephalogram fast rhythms and motor neuropathy were absent. Cerebellar atrophy, claval hypertrophy and pallidal hypointensity were evident at brain magnetic resonance imaging. This patient carried a missense variant predicted to be less deleterious. Conclusions: The PLAN-associated phenotypes and the challenges of diagnosing the childhood-onset form are delineated, and a common North African founder mutation is identifed.

Neurodegeneration associated with genetic defects in phospholipase A(2)

PLA2G6-Associated Neurodegeneration (PLAN): Review of Clinical Phenotypes and Genotypes

Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.

Infantile onset progressive cerebellar atrophy and anterior horn cell Degeneration-A novel phenotype associated with mutations in the PLA2G6 gene

Novel PLA2G6 mutations and clinical heterogeneity in Chinese cases with phospholipase A2-associated neurodegeneration.

A systematic analysis of genotype–phenotype associations with PLA2G6

The role of NOTCH2NLC in Parkinson's disease: A clinical, neuroimaging, and pathological study

Monozygotic Twins with Infantile Neuroaxonal Dystrophy: A Case Report and Literature Review

Clinical Study and PLA2G6 Mutation Screening Analysis in Chinese Patients with Infantile Neuroaxonal Dystrophy

PNPLA6 disorders: what's in a name?

Unveiling the role of iPLA2β in neurodegeneration: From molecular mechanisms to advanced therapies

An estimation of global genetic prevalence of PLA2G6-associated neurodegeneration

Novel PLA2G6 Pathogenic Variants in Chinese Patients With PLA2G6-Associated Neurodegeneration

A Novel Homozygous Mutation in PLA2G6 Gene Causes Infantile Neuroaxonal Dystrophy in a Case

Early-Onset Parkinson's Disease Caused by PLA2G6 Compound Heterozygous Mutation, a Case Report and Literature Review

Identification of Novel Compound Mutations in PLA2G6-Associated Neurodegeneration Patient with Characteristic MRI Imaging

Infantile and childhood onset PLA2G6-associated neurodegeneration in a large North African cohort

The Clinical, Radiological and Genetic Spectrum of PLA2G6-Associated Neurodegeneration: An Experience From a Tertiary Center

The Clinical Characteristics and Molecular Genetics of Infantile Neuroaxonal Dystrophy: the Current Research Progress

Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A2β Knockout Mice

Follow-Up Study of 25 Chinese Children with Pla2g6-Associated Neurodegeneration